Actively Recruiting
Study of Clinical and Biological Features in Children, Adolescents, and Young Adults Under 30 With Myeloproliferative Neoplasia
Led by University Hospital, Brest · Updated on 2024-12-04
200
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are creating a national database to gather solid data about the diagnosis and care of children, adolescents, and young adults under 30 with myeloproliferative neoplasia MPN. This database aims to provide a clear picture of patient care and help identify biological samples available in routine labs. These samples can be reanalyzed by researchers to refine diagnoses and discover new molecular factors related to disease prognosis. This observational study involves collecting clinical and biological information from patients diagnosed with non-chronic myelogenous leukemia MPN types, including polycythemia vera, thrombocythemia, myelofibrosis, or pre-myelofibrosis, based on WHO criteria. Participants provide consent and agree to be part of the study as they are enrolled. There are no interventional treatments or drugs involved. Participants will have their clinical and molecular data recorded at enrollment to describe the epidemiological and mutational features of their condition. The study will also track long-term outcomes over 10 years to better understand disease progression and complications. The involvement includes providing consent, allowing access to medical and biological records, and long-term follow-up through the database.
CONDITIONS
Brief Title
Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)
Research Team
J
Jean-Christophe IANOTTO
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here